Showing results (531-540 of 788) with videos related to

Sort By:
Pageof 79
The Journal of Antimicrobial Chemotherapy|June 22, 2019
Changes in liver stiffness after ART initiation in HIV-infected Nigerian adults with and without chronic HBVJennifer L Grant, Patricia Agaba, Placid Ugoagwu, et al.
World Neurosurgery|September 16, 2019
Discharge Disposition After Anterior Cervical Discectomy and FusionAditya V Karhade, Paul T Ogink, Quirina C B S Thio, et al.
Biomaterials|October 8, 2018
The effects of a functionally-graded scaffold and bone marrow-derived mononuclear cells on steroid-induced femoral head osteonecrosisMasahiro Maruyama, Akira Nabeshima, Chi-Chun Pan, et al.
JCI Insight|December 8, 2022
Identification of a PD-L1+Tim-1+ iNKT subset that protects against fine particulate matter-induced airway inflammationChristina Li-Ping Thio, Alan Chuan-Ying Lai, Jo-Chiao Wang, et al.
Nutrients|May 14, 2025
Nutrition and Exercise Knowledge, Attitude, and Practice: A Scoping Review of Assessment Questionnaires in Cancer SurvivorshipZhi Qi Hoe, Ria Joseph, Narayanee Dick, et al.
AIDS (London, England)|February 1, 2019
Hepatitis B virus coinfection is associated with high early mortality in HIV-infected Tanzanians on antiretroviral therapyBeatrice Christian, Emanuel Fabian, Irene Macha, et al.
The Journal of Infectious Diseases|September 22, 2011
Genetic polymorphism in IL28B is associated with spontaneous clearance of hepatitis C virus genotype 4 infection in an Egyptian cohortFuat Kurbanov, Mohamed Abdel-Hamid, Rachel Latanich, et al.
Clinical Drug Investigation|August 27, 2013
Pharmacokinetics and safety of golimumab in healthy Chinese subjects following a single subcutaneous administration in a randomized phase I trialYanli Zhuang, Sally Lyn, Yuan Lv, et al.
European Journal of Immunology|February 10, 2004
Monomethylfumarate affects polarization of monocyte-derived dendritic cells resulting in down-regulated Th1 lymphocyte responsesNicolle H R Litjens, Mirjam Rademaker, Bep Ravensbergen, et al.
Arthritis and Rheumatism|August 1, 2008
Is imatinib mesylate a promising drug in systemic sclerosis?P L A van Daele, W A Dik, H B Thio, et al.
Pageof 79